Typical Protocol: Commonly discussed protocols cite 150-400 mcg administered via subcutaneous or intramuscular injection, 2-3 times per week, over cycles of roughly 8-10 weeks
Product Highlights: Peptide Content: BPC-157 and TB-500 per vial Form: Lyophilized powder, requires reconstitution Purity: Verified through independent third-party laboratory testing Packaging: Supplied in sterile, tamper-evident sealed vial Intended Use: For in vitro laboratory research only Not intended for diagnostic or therapeutic purposes Usage Instructions: This product is intended for use only by qualified professionals in controlled laboratory environments
AOD 9604 isnt appropriate for everyone, such as those who: Before starting, inform your prescriber if youre taking the following medication to prevent harmful drug interactions: Your licensed clinician should run baseline laboratory tests before starting your dosing, which they must always supervise
Gut 70 , 962969 (2021)
That is KLOW
Recalls & Warnings November 21, 2012 Maker of Probiotic and Sports Drinks Warned For Manufacturing Violations On November 6, 2012, the FDA issued a warning letter to CocoKefir, LLC stating that the company's Tula's CocoKefir, Tula's Citrus CocoKefir, and Tula's Apple Cinnamon CocoKefir have been prepared, packed or held under conditions which violate Current Good Manufacturing Practices